Shell Asset Management CO Legend Biotech Corp Transaction History
Shell Asset Management CO
- $2.27 Billion
- Q3 2024
A detailed history of Shell Asset Management CO transactions in Legend Biotech Corp stock. As of the latest transaction made, Shell Asset Management CO holds 1,290 shares of LEGN stock, worth $51,832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,290
Previous 1,790
27.93%
Holding current value
$51,832
Previous $79,000
20.25%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LEGN
# of Institutions
212Shares Held
77.9MCall Options Held
412KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$462 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$302 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$267 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$230 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$202 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.73B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...